36 participants
Open-Label Safety, PK, and Efficacy Trial of Sebetralstat (KVD900) in Pediatric Patients (Ages 2-11) With HAE Type I or II
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-08-05
- Start Date:
- 2024-08-01
- Completion:
- 2026-01-15
Conditions
- Hereditary Angioedema
Interventions
- DRUG